U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599605) titled 'Prophylaxis Against Post-Endoscopic Retrograde Cholangio-Pancreatography Pancreatitis.' on March 10.
Brief Summary: Endoscopic retrograde cholangiopancreatography (ERCP) is a key procedure for managing biliopancreatic diseases, although it is associated with complications such as post-ERCP pancreatitis. This study assessed the efficacy of a prophylactic protocol combining rectal indomethacin with aggressive hydration to reduce the incidence of post-ERCP pancreatitis and serum amylase and lipase levels.
Study Start Date: March 04, 2024
Study Type: INTERVENTIONAL
Condition:
Pancreatitis
ERCP
Intervention:
DRUG: Rectal Indometacin...